Vaccin moderna - activities

Covid: three Omicron-specific vaccines approved by the French Health Authority

As an umpteenth Covid wave threatens France this Fall, the French Health Authority (HAS) announced this Tuesday September 20, 2022, they approved the issuance in France of three Omicron-specific vaccines to effectively fight against the virus and transmission. “Bivalent” vaccines developed by Pfizer/BioNTech and Moderna, all three approved earlier by the European Medicines Agency.

Omicron variant: current vaccines likely less effectives, according to Moderna CEO

Shall one fear a major loss in the effectiveness of the current vaccines because of the Omicron variant? Interview by the Financial Times, Moderna CEO Stéphane Bancel expects a “material drop” in the Covid vaccines effectiveness currently given.

Covid: the French government confirms Moderna’s vaccine is halted for people under 30

France follows Sweden and no longer recommends to use Moderna’s vaccine in people under 30, following a report from the Haute Autorité de Santé. And for good reason, an increase risk of myocarditis and pericarditis. The French government followed the health authorities’ recommendation and now halts the use of the vaccine for the youngest.

Covid: the second dose of Moderna could lead to an increased risk of myocarditis

According to a pharmacovigilance report, the second dose of Moderna’s Covid-19 vaccine could be associated with more frequent cases of myocarditis in men under the age of 30.

Covid: vaccine coming as an intranasal spray, pill or powder… More on the ongoing researches

As Covid vaccine campaigns go on across the world, searchers keep working on new ways to give the vaccine. Spray, pill, powder… Keep reading to find out more about the ongoing researches!

Covid: the government speaks about two billion euros to buy vaccines in 2022

The French government plans to spend two billion euros to vaccinate against Covid-19 in 2022. But how will all these doses be useful?

Covid: when faced with the Delta variant, Moderna vaccine more effective than Pfizer, according to a study

According to a preliminary US study, the Moderna vaccine is far more effective against the Delta variant of Covid-19 than the Pfizer vaccine.

Covid vaccine: Moderna vaccine effective for at least 6 months, the company says

The American company has released results from the second quarter and confirms their Covid vaccine is effective for at least 6 months.

Covid: mixing mRNA and viral vector vaccines likely to reinforce immunity, a study found

Receiving two doses of vaccines with different technologies (mRNA and viral vector) is likely to increase immunity against Covid, a study released this past July 26 in Nature magazine found. Keep reading to find out more!

Covid vaccines: side effects reported and listed in France

Vaccination goes on in France and the health authorities are thoroughly monitoring the different vaccines available. Here is the list of side effects reported in France.

Covid: occupational health doctors can order Moderna vaccine doses online

After GPs and pharmacists, occupational health doctors are now allowed to order Moderna vaccine doses online, the French Department of Labor announced this June 9th.

Covid: can you get another vaccine for the 2nd shot?

Is it possible to get another vaccine for the 2nd shot? Medical interest, governmental authorization, here is more about this "mix and match" option likely to enable us to change vaccine during the process... or not.

Covid vaccine: a third dose required for people at risk from this summer, according to Moderna

Moderna Therapeutics French CEO Stéphane Bancel has announced this Saturday May 22 to our peers from JDD a third dose of Covid vaccine would be necessary from the end of summer for people at risk to extend immunity and prevent a new epidemic wave caused by variants. He also announced he sought approval in Europe to vaccinate teenagers.

Covid: a 3rd dose of Moderna vaccine to be working against variants, a study found

Is Moderna’s Covid vaccine effective against Brazilian and South African variants after a third dose? This is what the American laboratory found this Wednesday May 5, releasing the preliminary and encouraging results of phase 2 of their clinical trial on the matter.

Covid: WHO approves Moderna’s vaccine for emergency use

This Friday April 30, WHO announced they have approved Moderna’s vaccine for emergency use. Good news for disadvantaged countries.

Covid vaccine: answers to questions you may have

As Covid vaccination is growing in France, many of you are wondering about the vaccines and how such an action is useful to curb the spread of the virus. Questions the editorial board tries to answer to.

Covid: vaccine doses to be anonymized in France?

As more and more French distrust some Covid vaccines, Europe 1 radio station reports the Health Minister is considering anonymizing doses and therefore no longer tell the name of the vaccine given to the person during the appointment.

Covid: the time period between Pfizer and Moderna vaccine doses will be extended to 42 days

Olivier Véran announced in an interview with Journal du Dimanche that the time period between the two doses of vaccine will be extended to 42 days for patients given the Pfizer or Moderna vaccine.

Covid: Are the French giving Moderna vaccine the cold shoulder?

As the Covid vaccination campaign is growing in France, more and more French seem to be giving Moderna vaccine the cold shoulder yet said to be effective and statistically safer than other rivals’ products. For what reason? Keep reading to find out more.

Covid: the French Medicines Agency releases latest data about vaccine side effects

As the vaccination campaign is expected to increase even more in France over the coming weeks, the ANSM – the National Medicines Agency – has unveiled the conclusions of their latest investigation on side effects noticed following Covid-19 vaccination. Keep reading to find out more.